Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with pulmonary fibrosis (scarring of the lungs) by a specialist team, following internationally recognised medical guidelines
- People who are 18 years of age or older
Who may not be able to join:
- People who are not able to speak, read, or write in Dutch
- People who do not have access to the internet
- People whose treating doctor has estimated their life expectancy to be less than 1 year
- People who are currently using, or have previously used, a home monitoring program for pulmonary fibrosis
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marlies S. Wijsenbeek-Lourens, Prof Dr, Department of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center, Rotterdam, The Netherlands
Phone: +31650162675
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient self-management
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.